These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32664447)

  • 1. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
    Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
    Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
    J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
    Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
    Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
    Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
    Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
    Sarma NJ; Yaseen NR
    J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
    Sarma NJ; Yaseen NR
    PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
    PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.
    Oka M; Otani M; Miyamoto Y; Oshima R; Adachi J; Tomonaga T; Asally M; Nagaoka Y; Tanaka K; Toyoda A; Ichikawa K; Morishita S; Isono K; Koseki H; Nakato R; Ohkawa Y; Yoneda Y
    Cell Rep; 2023 Aug; 42(8):112884. PubMed ID: 37516964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype.
    Vaz M; Fahrenkrog B
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies.
    Takeda A; Yaseen NR
    Semin Cancer Biol; 2014 Aug; 27():3-10. PubMed ID: 24657637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with
    Mendes A; Jühlen R; Martinelli V; Fahrenkrog B
    Oncotarget; 2020 Sep; 11(36):3371-3386. PubMed ID: 32934780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
    Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
    Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
    Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
    J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
    Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
    PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)+ RNA Export.
    Port SA; Mendes A; Valkova C; Spillner C; Fahrenkrog B; Kaether C; Kehlenbach RH
    J Biol Chem; 2016 Oct; 291(44):23068-23083. PubMed ID: 27613868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the NUP98-CCDC28A fusion protein.
    Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
    Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).
    Fujino T; Suzuki A; Ito Y; Ohyashiki K; Hatano Y; Miura I; Nakamura T
    Blood; 2002 Feb; 99(4):1428-33. PubMed ID: 11830496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
    Pineault N; Abramovich C; Ohta H; Humphries RK
    Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.